A detailed history of Claro Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Claro Advisors LLC holds 5,546 shares of MRNA stock, worth $364,649. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,546
Previous 5,438 1.99%
Holding current value
$364,649
Previous $579,000 13.64%
% of portfolio
0.11%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$101.21 - $166.61 $10,930 - $17,993
108 Added 1.99%
5,546 $658,000
Q1 2024

Apr 18, 2024

SELL
$85.37 - $115.44 $14,854 - $20,086
-174 Reduced 3.1%
5,438 $579,000
Q4 2023

Jan 22, 2024

BUY
$69.51 - $104.43 $231,676 - $348,065
3,333 Added 146.25%
5,612 $558,000
Q3 2023

Oct 10, 2023

BUY
$96.41 - $126.61 $30,369 - $39,882
315 Added 16.04%
2,279 $235,000
Q2 2023

Aug 08, 2023

SELL
$118.5 - $160.53 $4,266 - $5,779
-36 Reduced 1.8%
1,964 $238,000
Q1 2023

Apr 17, 2023

SELL
$135.66 - $197.02 $15,872 - $23,051
-117 Reduced 5.53%
2,000 $307,000
Q4 2022

Mar 10, 2023

BUY
$118.38 - $210.04 $118 - $210
1 Added 0.05%
2,117 $380,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $28,056 - $49,779
-237 Reduced 10.07%
2,116 $380,000
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $37,013 - $55,802
-316 Reduced 11.84%
2,353 $336,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $39,292 - $64,120
174 Added 6.97%
2,669 $678,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $75,002 - $163,750
338 Added 15.67%
2,495 $960,000
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $91,716 - $165,895
-706 Reduced 24.66%
2,157 $507,000
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $64,088 - $109,170
587 Added 25.79%
2,863 $375,000
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $160,668 - $415,137
-2,444 Reduced 51.78%
2,276 $238,000
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $256,484 - $447,692
4,720 New
4,720 $334,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.